Skip to content
stockmarketcap
Discover
Top gainersTop losersMost activeMarket sectorsHeatmapTreasury rates
Earnings calendarIPO calendarEx-dividend calendarEconomic calendar
Congress tradesInsider tradesAnalyst upgrades & downgrades
Collections
ScreenerCompareBacktester
ValuationFundamentals
WatchlistPortfolioPricing
Sign in
Markets
StocksGainersLosersMost activeMarket sectorsHeatmapEarnings calendarCongress tradesInsider tradesAnalyst upgrades/downgradesIPO calendarEx-dividend calendar
Tools
ScreenerCompare stocksReturns backtesterPortfolio trackerWatchlistEmbeddable widget
Metrics
ValuationFundamentals
Popular lists
Best dividend stocksBest value stocksLargest companiesLowest P/E stocks
Collections
All lists & collectionsUS stocksJapanese stocksChinese stocksHong Kong stocksSouth Korean stocksTaiwanese stocksCanadian stocksUK stocksEuropean stocksMagnificent 7AI stocksSemiconductor stocks
Compare
Compare stocksFinviz alternativeKoyfin alternativeTradingView alternativeStockAnalysis alternative
Learn
Investing glossaryHelp & guide
StockMarketCapDocsTokenTermsPrivacyData for information only, not investment advice.
◆

GILD vs LLY

Gilead Sciences, Inc. and Eli Lilly and Company compared side by side. Customize this comparison

Performance (normalized)

-16%+94%+203%+313%+422%stockmarketcap.io

Key metrics

MetricGILD logoGILDLLY logoLLY
Price$129.61$1,200.06
Market cap$160.92B$1.13T
P/E ratio (TTM)17.03x42.53x
P/S ratio (TTM)5.28x15.63x
Dividend yield2.55%0.54%
Beta0.330.52
1-year return+15.95%+55.27%

Want return correlation and up to five stocks side by side? The advanced compare tool is part of Plus.